Gianluca Civenni
Bellinzona, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.
Journal: Oncogene
Published: September 03, 2024
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer.
Journal: Nature communications
Published: April 11, 2023
Proteomics of immune cells from liver tumors reveals immunotherapy targets.
Journal: Cell genomics
Published: September 28, 2022
Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease.
Journal: Nature communications
Published: July 15, 2021
Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ1 receptor affinity, antitumor and analgesic activity.
Journal: European journal of medicinal chemistry
Published: February 15, 2021
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer.
Journal: Nature communications
Published: October 27, 2020
Novel σ1 antagonists designed for tumor therapy: Structure - activity relationships of aminoethyl substituted cyclohexanes.
Journal: European journal of medicinal chemistry
Published: July 23, 2020
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer.
Journal: Communications biology
Published: July 22, 2020
Pharmacodynamic and Pharmacokinetic Properties of Full Phosphorothioate Small Interfering RNAs for Gene Silencing In Vivo.
Journal: Nucleic acid therapeutics
Published: April 21, 2020
Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer.
Journal: Molecular & cellular oncology
Published: June 20, 2019
Last Updated: 09/26/2026